This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lucas, A. Articles by McFadden, G. Search for Related Content PubMed PubMed Citation Articles by Lucas, A. Articles by McFadden, G.

(Circulation. 1996;94:2890-2900.)
© 1996 American Heart Association, Inc.

Articles

Virus-Encoded Serine Proteinase Inhibitor SERP-1 Inhibits Atherosclerotic Plaque Development After Balloon Angioplasty

Alexandra Lucas, MD; Li-ying Liu, MD; Joanne Macen, PhD; Piers Nash, BSc; Erbin Dai, MD; Michael Stewart, MSc; Kathryn Graham, PhD; Wai Etches, MD; Lynn Boshkov, MD; Patric N. Nation, MD; Dennis Humen, MD; Marita Lundstrom Hobman, PhD; Grant McFadden, PhD

the Division of Cardiology, Department of Medicine (A.L., L.-y.L., E.D., D.H., M.L.H.); the Department of Biochemistry (J.M., P.N., K.G., G.M.); Health Sciences Laboratory Animal Services (P.N.N.); the Department of Laboratory Medicine and Pathology (M.S., W.E., L.B.), University of Alberta, Edmonton, Alberta, Canada.

Correspondence to Dr Alexandra Lucas, John P. Robarts Research Institute, University of Western Ontario, PO Box 5015, 100 Perth Dr, London, Ontario N6A 5K8, Canada. E-mail arl@rri.uwo.ca.

Background Recurrent atherosclerotic plaque growth, restenosis, is a significant clinical problem after interventional procedures. Initiation of restenosis involves activation of inflammatory and thrombotic cascades, which are regulated by serine proteinase enzymes and inhibitors. We have investigated the use of a viral serine proteinase inhibitor, SERP-1, to reduce plaque development after primary balloon angioplasty. This is the first experimental report of the use of a viral anti-inflammatory protein for the prevention of atherosclerosis.

Methods and Results Seventy-four cholesterol-fed rabbits were treated with either local or systemic infusions of SERP-1 protein (or control solutions) after balloon-mediated injury. Sites of SERP-1 infusion in rabbits had dramatically reduced plaque compared with control infusions at the 4-week follow-up. At low-dose infusions (30 to 300 pg), only the primary infusion site had a demonstrable decrease in plaque, whereas at higher-dose infusions (>3000 pg), a generalized reduction in plaque development was detected. An associated decrease in mononuclear cell infiltration of the arterial wall was detected after SERP-1 infusion within the first 24 hours. Infusion of an active-site mutant of SERP-1 (P₁-P₁', ala-ala) lacking serine proteinase inhibitory activity failed to prevent plaque growth.

Conclusions Purified SERP-1, a virus-encoded secreted glycoprotein, reduces plaque growth after primary balloon-mediated injury. Plaque development is decreased by inhibition of serine proteinase activity and is associated with a focal reduction in macrophage infiltration immediately after injury. Investigation of serine proteinase inhibitors may provide new insight into the regulation of arterial responses to injury.

Key Words: plaque • serpin • angioplasty • immune system

This article has been cited by other articles:

				E. Dai, K. Viswanathan, Y. M. Sun, X. Li, L. Y. Liu, B. Togonu-Bickersteth, J. Richardson, C. Macaulay, P. Nash, P. Turner, et al. Identification of Myxomaviral Serpin Reactive Site Loop Sequences That Regulate Innate Immune Responses J. Biol. Chem., March 24, 2006; 281(12): 8041 - 8050. [Abstract] [Full Text] [PDF]

				A. Garcia-Touchard, T. D. Henry, G. Sangiorgi, L. G. Spagnoli, A. Mauriello, C. Conover, and R. S. Schwartz Extracellular Proteases in Atherosclerosis and Restenosis Arterioscler. Thromb. Vasc. Biol., June 1, 2005; 25(6): 1119 - 1127. [Abstract] [Full Text] [PDF]

				A. Lucas and G. McFadden Secreted Immunomodulatory Viral Proteins as Novel Biotherapeutics J. Immunol., October 15, 2004; 173(8): 4765 - 4774. [Abstract] [Full Text] [PDF]

				I. Bot, J. H. von der Thusen, M. M.P.C. Donners, A. Lucas, M. L. Fekkes, S. C.A. de Jager, J. Kuiper, M. J.A.P. Daemen, T. J.C. van Berkel, S. Heeneman, et al. Serine Protease Inhibitor Serp-1 Strongly Impairs Atherosclerotic Lesion Formation and Induces a Stable Plaque Phenotype in ApoE-/- Mice Circ. Res., September 5, 2003; 93(5): 464 - 471. [Abstract] [Full Text] [PDF]

				J. B. Johnston and G. McFadden Poxvirus Immunomodulatory Strategies: Current Perspectives J. Virol., June 1, 2003; 77(11): 6093 - 6100. [Full Text] [PDF]

				E. Dai, H. Guan, L. Liu, S. Little, G. McFadden, S. Vaziri, H. Cao, I. A. Ivanova, L. Bocksch, and A. Lucas Serp-1, a Viral Anti-inflammatory Serpin, Regulates Cellular Serine Proteinase and Serpin Responses to Vascular Injury J. Biol. Chem., May 9, 2003; 278(20): 18563 - 18572. [Abstract] [Full Text] [PDF]

				S. Wen, R. M. Driscoll, D. B. Schneider, and D. A. Dichek Inclusion of the E3 Region in an Adenoviral Vector Decreases Inflammation and Neointima Formation After Arterial Gene Transfer Arterioscler. Thromb. Vasc. Biol., November 1, 2001; 21(11): 1777 - 1782. [Abstract] [Full Text] [PDF]

				L. W. Miller, E. Dai, P. Nash, L. Liu, C. Icton, D. Klironomos, L. Fan, P. N. Nation, R. Zhong, G. McFadden, et al. Inhibition of Transplant Vasculopathy in a Rat Aortic Allograft Model After Infusion of Anti-Inflammatory Viral Serpin Circulation, April 4, 2000; 101(13): 1598 - 1605. [Abstract] [Full Text] [PDF]

				K. Sujino, R. J. Jackson, N. W. C. Chan, S. Tsuji, and M. M. Palcic A novel viral {alpha}2,3-sialyltransferase (v-ST3Gal I): transfer of sialic acid to fucosylated acceptors Glycobiology, March 1, 2000; 10(3): 313 - 320. [Abstract] [Full Text] [PDF]

				A. Lucas and G. McFadden Harvesting viral proteins Can. Med. Assoc. J., November 1, 1999; 161(9): 1134 - 1134. [Full Text] [PDF]

				P. C. Turner, M. C. Sancho, S. R. Thoennes, A. Caputo, R. C. Bleackley, and R. W. Moyer Myxoma Virus Serp2 Is a Weak Inhibitor of Granzyme B and Interleukin-1beta -Converting Enzyme In Vitro and Unlike CrmA Cannot Block Apoptosis in Cowpox Virus-Infected Cells J. Virol., August 1, 1999; 73(8): 6394 - 6404. [Abstract] [Full Text]

				U. Schonbeck, F. Mach, G. K. Sukhova, E. Atkinson, E. Levesque, M. Herman, P. Graber, P. Basset, and P. Libby Expression of Stromelysin-3 in Atherosclerotic Lesions: Regulation via CD40-CD40 Ligand Signaling In Vitro and In Vivo J. Exp. Med., March 1, 1999; 189(5): 843 - 853. [Abstract] [Full Text] [PDF]

				P. Nash, A. Whitty, J. Handwerker, J. Macen, and G. McFadden Inhibitory Specificity of the Anti-inflammatory Myxoma Virus Serpin, SERP-1 J. Biol. Chem., August 14, 1998; 273(33): 20982 - 20991. [Abstract] [Full Text] [PDF]

				P. Carmeliet, L. Moons, R. Lijnen, S. Janssens, F. Lupu, D. Collen, and R. D. Gerard Inhibitory Role of Plasminogen Activator Inhibitor-1 in Arterial Wound Healing and Neointima Formation : A Gene Targeting and Gene Transfer Study in Mice Circulation, November 4, 1997; 96(9): 3180 - 3191. [Abstract] [Full Text]

				E. Dai, M. Stewart, B. Ritchie, N. Mesaeli, S. Raha, D. Kolodziejczyk, M. L. Hobman, L. Y. Liu, W. Etches, N. Nation, et al. Calreticulin, a Potential Vascular Regulatory Protein, Reduces Intimal Hyperplasia After Arterial Injury Arterioscler. Thromb. Vasc. Biol., November 1, 1997; 17(11): 2359 - 2368. [Abstract] [Full Text]

				E. Haber Can a Viral Serine Proteinase Inhibitor Prevent Postangioplasty Restenosis? Circulation, December 1, 1996; 94(11): 2694 - 2695. [Full Text]